NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab - Vigipallia

0 avis

NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

Archive ouverte

Ajuria, L. Carril | Naigeon, M. | Dalban, C. | Desnoyer, A. | Rioux-Leclercq, N. | Sautes-Fridman, C. | Meylan, M. | Vano, Y. | Beuselinck, B. | Chouaib, S. | de Oliveira, C. | Tantot, Olivier | Escudier, B. | Albiges, L. | Chaput, N.

Edité par CCSD ; Elsevier -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

Archive ouverte | Kinget, L. | CCSD

International audience

Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N)

Archive ouverte | Meylan, M. | CCSD

International audience

Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients

Archive ouverte | Charrier, M. | CCSD

International audience

Chargement des enrichissements...